Ezequiel Mauro
@ezemauro_ok
Hepatology - Liver Cancer - Liver Transplant.
Liver Unit - Hospital Clinic of Barcelona - IDIBAPS
Lover of medicine, chess, polo and roller hockey.
ID: 1248254528983531520
09-04-2020 14:20:53
1,1K Tweet
760 Followers
1,1K Following
Panel discussion on personalizing early diagnosis of #biliarycancer at the ENS-CCA Precision-BTC-Network meeting in Krakow Rocío IR Macías chiara braconi Chiara Gabbi Liver Growth and Cancer Lab Lewis Roberts Jesus Bañales Alejandro Forner Pedro Rodrigues
🔥off the press: Whole-exome sequencing reveals novel cancer genes & actionable targets in biliary tract cancers in PSC Hepatology Communications doi.org/10.1097/HC9.00… 👉Interesting data on molecular underpinnings of PSC- CCA 😅more to come, stay tuned.. EASLnews ESMO - Eur. Oncology ILCA
❓What are the predictors of aggressive recurrence of HCC after resection? Journal of Hepatology ➡️Aggressive recurrence: exceeding the Milan criteria at 1st recurrence 🚨35% ❗️Microvascular invasion and/or satellitosis is the only independent risk factor for aggressive recurrence
📢¡Novedades! Te presentamos la imagen para nuestro 50º Congreso Anual, que coincide también con nuestro 50 Aniversario, en 2025. 📅Habrá un día más de Congreso, del 25 al 28 de febrero en el Hotel Melia_Castilla de #Madrid. Atentos porque pronto daremos más información. ¡Será
Elliot Tapper ➡️ Saying that this is the end for sec prophylaxis of SBP is a big saying!Surveys where 50% of pts receive treatment and the rest not, do not provide the same quality of information as a RCT! 😱 ✅ As JP Benhamou used to say, “when I don’t know what is best, I randomize”
Happy to share our manuscript Liver stiffness measurement predicts clinical outcomes in autoimmune h... sciencedirect.com/science/articl… ☑️ LSM >8.5 predicts cirrhosis and liver-related outcomes in AIH JHEP Reports Asociación Española para el Estudio del Hígado Álvaro Díaz-González Mar Riveiro EASLnews
Excited for the participation of the Clinic Barcelona Comprehensive Cancer Center at #ESMO24 ! Hospital Clínic IDIBAPS Universitat de Barcelona Our investigators contributing to 35 studies: ✅ 1 Presidential Symposium ✅ 4 Proffered Paper Presentations ✅ 7 Mini-oral Presentations ✅
GLP-1 drugs associated with reduction of cirrhosis and all-cause mortality in participants with MASLD (metabolic-dysfunction associated steatotic liver disease), but without effect in those with pre-existing cirrhosis. jamanetwork.com/journals/jamai… JAMA Internal Medicine Fasiha Kanwal